Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity. (Q51143927)

From Wikidata
Jump to navigation Jump to search
scientific article published on 4 November 2013
edit
Language Label Description Also known as
English
Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity.
scientific article published on 4 November 2013

    Statements

    Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit